FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

PharMEDium Services 0.9% Buffered Lidocaine HCl Recall

0.9% Buffered Lidocaine HCl (buffered in 8.4% Sodium Bicarbonate) a.) 1 mL in 3 mL BD S…

PharMEDium Services, LLC. · Cleveland, MS

Risk level
Class II
Reported by FDA
Jan 16, 2019
Recall ID
D-0374-2019
Check your lot numberHow we source this data

Summary

PharMEDium Services recalled 0.9% Buffered Lidocaine HCl starting Jan 2, 2019. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0374-2019 on Jan 16, 2019. Reason: Subpotent. Status: Terminated.

Why it was recalled

Subpotent

Product description

0.9% Buffered Lidocaine HCl (buffered in 8.4% Sodium Bicarbonate) a.) 1 mL in 3 mL BD Syringe, 10 per carton, b.) 0.9% Buffered Lidocaine HCl (buffered in 8.4% Sodium Bicarbonate) 5 mL in 5 mL BD Syringe, 10 per carton Rx Only, Compounded by PharMEDium Services, LLC, Sugar Land, TX 77478.

Lot numbers, UPCs & expiration codes

Service Code 2K2466 and 2K2470 183320004S, 183330008S, 183340002S, 183340003S, 183300004S, 183310007S, 183370041S, 183310043S, 183370042S, 183320003S, 183380007S, 183250013S, 183250014S, 183320005S, 183330009S, 183370007S, 183390044S, 183400006S, 183410003S.

Where it was sold

Product was distributed throughout the United States.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0374-2019
Classification
Class II
Status
Terminated
Recall initiated
Jan 2, 2019
FDA report date
Jan 16, 2019
Quantity
7,711 syringes
Recall type
Voluntary: Firm initiated
Recalling firm
PharMEDium Services, LLC.

Original FDA data

Every field from FDA enforcement report D-0374-2019, exactly as published.

Show all FDA fields
City
Cleveland
State
MS
Status
Terminated
Country
United States
Event ID
81895
Address
913 N Davis Ave
Code information
Service Code 2K2466 and 2K2470 183320004S, 183330008S, 183340002S, 183340003S, 183300004S, 183310007S, 183370041S, 183310043S, 183370042S, 183320003S, 183380007S, 183250013S, 183250014S, 183320005S, 183330009S, 183370007S, 183390044S, 183400006S, 183410003S.
Postal code
38732-2106
Report date
Jan 16, 2019
Product type
Drugs
Recall number
D-0374-2019
Classification
Class II
Recalling firm
PharMEDium Services, LLC.
Product quantity
7,711 syringes
Termination date
May 7, 2020
Reason for recall
Subpotent
Voluntary / mandated
Voluntary: Firm initiated
Product description
0.9% Buffered Lidocaine HCl (buffered in 8.4% Sodium Bicarbonate) a.) 1 mL in 3 mL BD Syringe, 10 per carton, b.) 0.9% Buffered Lidocaine HCl (buffered in 8.4% Sodium Bicarbonate) 5 mL in 5 mL BD Syringe, 10 per carton Rx Only, Compounded by PharMEDium Services, LLC, Sugar Land, TX 77478.
Distribution pattern
Product was distributed throughout the United States.
Recall initiation date
Jan 2, 2019
Initial firm notification
Letter
Center classification date
Jan 14, 2019

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0374-2019, published Jan 16, 2019. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls